Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tecogen (TGEN) Research & Development (2016 - 2025)

Tecogen's Research & Development history spans 13 years, with the latest figure at $307426.0 for Q4 2025.

  • For Q4 2025, Research & Development rose 35.52% year-over-year to $307426.0; the TTM value through Dec 2025 reached $1.2 million, up 21.3%, while the annual FY2025 figure was $1.2 million, 21.3% up from the prior year.
  • Research & Development reached $307426.0 in Q4 2025 per TGEN's latest filing, up from $297926.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $307426.0 in Q4 2025 to a low of $122031.0 in Q3 2021.
  • Average Research & Development over 5 years is $212177.2, with a median of $220581.5 recorded in 2023.
  • Peak YoY movement for Research & Development: crashed 65.38% in 2021, then skyrocketed 65.64% in 2022.
  • A 5-year view of Research & Development shows it stood at $161015.0 in 2021, then rose by 21.57% to $195747.0 in 2022, then rose by 9.49% to $214320.0 in 2023, then rose by 5.84% to $226843.0 in 2024, then soared by 35.52% to $307426.0 in 2025.
  • Per Business Quant, the three most recent readings for TGEN's Research & Development are $307426.0 (Q4 2025), $297926.0 (Q3 2025), and $268724.0 (Q2 2025).